TrialCritical care (London, England)2012

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.

Ivan Chytra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.